The latest closing stock price for 4D Molecular Therapeutics as of April 01, 2025 is 2.99.
An investor who bought $1,000 worth of 4D Molecular Therapeutics stock at the IPO in 2020 would have $-926 today, roughly -1 times their original investment - a -47.87% compound annual growth rate over 4 years.
The all-time high 4D Molecular Therapeutics stock closing price was 52.67 on February 11, 2021.
The 4D Molecular Therapeutics 52-week high stock price is 29.27, which is 878.9% above the current share price.
The 4D Molecular Therapeutics 52-week low stock price is 2.87, which is 4% below the current share price.
The average 4D Molecular Therapeutics stock price for the last 52 weeks is 13.49.
An investor who bought $1,000 worth of 4D Molecular Therapeutics stock at the IPO in 2020 would have $-926 today, roughly -1 times their original investment - a -47.87% compound annual growth rate over 4 years.
The all-time high 4D Molecular Therapeutics stock closing price was 52.67 on February 11, 2021.
The 4D Molecular Therapeutics 52-week high stock price is 29.27, which is 878.9% above the current share price.
The 4D Molecular Therapeutics 52-week low stock price is 2.87, which is 4% below the current share price.
The average 4D Molecular Therapeutics stock price for the last 52 weeks is 13.49.